Stat5 is a prognostic marker for ER-positive breast cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷 / 2期
关键词：
D O I：
10.1038/ncponc0701
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：66 / 66
相关论文
共 50 条
  • [21] Predicting late recurrence in ER-positive breast cancer
    Cuzick, Jack
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) : 406 - 408
  • [22] The role of the AR/ER ratio in ER-positive breast cancer patients
    Rangel, Nelson
    Rondon-Lagos, Milena
    Annaratone, Laura
    Osella-Abate, Simona
    Metovic, Jasna
    Mano, Maria Piera
    Bertero, Luca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 163 - 172
  • [23] Evaluation of the OncoMasTR prognostic signature in postmenopausal women with primary ER-positive breast cancer.
    Sestak, Ivana
    Buus, Richard
    Cuzick, Jack M.
    Barron, Stephen
    Loughman, Tony
    Fender, Bozena
    Ruiz, Cesar Lopez
    Dynoodt, Peter
    Wang, Chan-Ju Angel
    O'Leary, Desmond
    Gallagher, William M.
    Dowsett, Mitchell
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
    Zhou, Meng
    Gan, Xing-li
    Ren, Yue-xiang
    Chen, Qian-xin
    Yang, Yuan-zhong
    Weng, Zi-jin
    Zhang, Xiao-fang
    Guan, Jie-xia
    Tang, Lu-ying
    Ren, Ze-fang
    BMC CANCER, 2023, 23 (01)
  • [25] AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
    Meng Zhou
    Xing-li Gan
    Yue-xiang Ren
    Qian-xin Chen
    Yuan-zhong Yang
    Zi-jin Weng
    Xiao-fang Zhang
    Jie-xia Guan
    Lu-ying Tang
    Ze-fang Ren
    BMC Cancer, 23
  • [26] Quantitative Expression of Estrogen Receptor on Relapse Biopsy for ER-positive Breast Cancer: Prognostic Impact
    Dieci, Maria Vittoria
    Piacentini, Federico
    Dominici, Massimo
    Omarini, Claudia
    Goubar, Aicha
    Ficarra, Guido
    Conte, Pierfranco
    Guarneri, Valentina
    ANTICANCER RESEARCH, 2014, 34 (07) : 3657 - 3662
  • [27] The prognostic effects of somatic mutations in ER-positive breast cancer (vol 9, 3476, 2018)
    Griffith, Obi L.
    Spies, Nicholas C.
    Anurag, Meenakshi
    Griffith, Malachi
    Luo, Jingqin
    Tu, Dongsheng
    Yeo, Belinda
    Kunisaki, Jason
    Miller, Christopher A.
    Krysiak, Kilannin
    Hundal, Jasreet
    Ainscough, Benjamin J.
    Skidmore, Zachary L.
    Campbell, Katie
    Kumar, Runjun
    Fronick, Catrina
    Cook, Lisa
    Snider, Jacqueline E.
    Davies, Sherri
    Kavuri, Shyam M.
    Chang, Eric C.
    Magrini, Vincent
    Larson, David E.
    Fulton, Robert S.
    Liu, Shuzhen
    Leung, Samuel
    Voduc, David
    Bose, Ron
    Dowsett, Mitch
    Wilson, Richard K.
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    NATURE COMMUNICATIONS, 2018, 9
  • [28] A simple and reproducible prognostic index in luminal ER-positive breast cancers
    Castellano, I.
    Chiusa, L.
    Vandone, A. M.
    Beatrice, S.
    Goia, M.
    Donadio, M.
    Arisio, R.
    Muscara, F.
    Durando, A.
    Viale, G.
    Cassoni, P.
    Sapino, A.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2292 - 2297
  • [29] Prognostic Significance of Mammographic Density Change After Initiation of Tamoxifen for ER-Positive Breast Cancer
    Nyante, Sarah J.
    Sherman, Mark E.
    Pfeiffer, Ruth M.
    de Gonzalez, Amy Berrington
    Brinton, Louise A.
    Bowles, Erin J. Aiello
    Hoover, Robert N.
    Glass, Andrew
    Gierach, Gretchen L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (03):
  • [30] SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer
    Zwart, Wilbert
    Flach, Koend.
    Rudraraju, Bharath
    Abdel-Fatah, Tarek M. A.
    Gojis, Ondrej
    Canisius, Sander
    Moore, David
    Nevedomskaya, Ekaterina
    Opdam, Mark
    Droog, Marjolein
    Hofland, Ingrid
    Chan, Steve
    Shaw, Jacqui
    Ellis, Ian O.
    Coombes, R. Charles
    Carroll, Jason S.
    Ali, Simak
    Palmieri, Carlo
    CLINICAL CANCER RESEARCH, 2016, 22 (02) : 479 - 491
12345